Raynews

Rayner’s 10-Year Milestones in 2017

Posted on 17/01/2018

For immediate release Ten year milestones achieved for key Primary & Supplementary IOLs. 2017 in review. 18th January, 2018. Worthing, United Kingdom. Over the course of 2017, Rayner marked the ten year anniversary for receiving CE approval for the following IOLs: Sulcoflex Aspheric C-flex Aspheric Superflex Aspheric M-flex T Multifocal Toric Milestone one: Sulcoflex Aspheric Supplementary IOL: A solution to

Read more


India Surgeons Now Use RayOne IOL

Posted on 17/10/2017

For immediate release. Date: 17 October, 2017. Surgeons in India to access RayOne fully preloaded IOL injection system. British IOL manufacturer, Rayner, announced today that their new RayOne fully preloaded IOL injection system has received Central Drugs Standard Organisation (CDSCO) approval and is being launched in India. Product approval details The CDSCO granted regulatory approval and sale

Read more


Rayner’s Product Launches at 2017 ESCRS

Posted on 26/09/2017

Rayner announced today it’s schedule of events and opportunities for surgeons during the upcoming ESCRS Congress, on the Rayner booth #P207 (Pavilion 2), which includes the launch of the RayOne Trifocal IOL and a preview of the RayOne Hyd...

Read more


Keeping it simple: The new Rayner website experience

Posted on 22/09/2017

For those of you who have visited the Rayner website over the last few days, you will have noticed we’re now offering a very different online experience; one that we believe is clearer and more user-friendly.

It’s al...

Read more


RayOne Trifocal Launch at ESCRS

Posted on 14/09/2017

For immediate release. 14 September, 2017. Rayner are proud to announce the launch of the newest member of the RayOne family of preloaded IOLs: the RayOne Trifocal, to be unveiled at the upcoming 2017 ESCRS conference in Lisbon. Product availability will be from 9 October 2017 to all CE registered markets. The most advanced lens design Rayner

Read more


Rayner Strengthens US Market Presence

Posted on 7/09/2017

For immediate release. Rayner strengthens commitment to US market with subsidiary Rayner Surgical Inc. 7 September, 2017. With a large part of 2016 and 2017 focused on European expansion, Rayner announced today its investment into the US market with the establishment of a dedicated subsidiary, ‘Rayner Surgical Inc.’Based out of New York, Rayner Surgical Inc. will provide

Read more


RayOne Fully Preloaded IOL Injection System. Now available in Brazil.

Posted on 11/07/2017

For immediate release. Date: 11 July, 2017. RayOne Fully Preloaded IOL Injection System. Now available in Brazil. More surgeons to access the smallest Fully Preloaded IOL Incision Rayner announced today the latest update in the RayOne story: registration of the RayOne Aspheric and Spheric monofocal fully preloaded IOL injection systems has been listed in the Federal Register

Read more


RayOne Shines in intraocular lens (IOL) Study Results

Posted on 19/06/2017

An experimental study was recently conducted to compare current fully preloaded intraocular lens (IOL) injection systems on the market. 

The study explored wound architecture after IOL implantation and the overall ease and speed...

Read more

IOL

Rayner marks ten years of C-flex in the USA

Posted on 24/04/2017

For immediate release. Rayner marks ten years of C-flex in the USA 14 March 2017. Worthing, United Kingdom. Rayner announced today that it will mark an important milestone next month: the ten year anniversary of US Food and Drug Administration (FDA) approval of C-flex 570C monofocal Intraocular Lens (IOL) for commercial use in the United States of America.

Read more


Refractive Cataract Chinese Surgeons Access Rayner IOL

Posted on 27/02/2017

For immediate release. March 02, 2017 – Worthing, United Kingdom. Rayner announced today that a selection of models in their Sulcoflex range of pseudophakic supplementary IOLs have received Chinese Food and Drug Administration (CFDA) approval and are to be launched in market in 2017. Rayner is the first manufacturer to make a supplementary IOL available to surgeons in

Read more